Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. ONMD
stocks logo

ONMD

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Onemednet Corp (ONMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Onemednet Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

ONMD News & Events

Events Timeline

(ET)
2025-11-24
08:56:03
OneMedNet to unveil innovative platform at RSNA 2025
select
2025-11-17 (ET)
2025-11-17
07:47:28
OneMedNet Announces Q3 Bookings of $1.1M, Marking an 815% Year-Over-Year Growth
select
2025-11-10 (ET)
2025-11-10
07:59:21
OneMedNet to showcase its iRWD platform at ISPOR
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
11-28NASDAQ.COM
Insider Buying Update for Friday, November 28: EXEL, ONMD
  • Exelixis Insider Purchase: Director David Edward Johnson bought 27,532 shares of EXEL at $43.12 each, totaling $1.19M, marking his first purchase in a year. EXEL's stock was up about 0.7% on Friday, reaching a high of $44.85.

  • OneMedNet Insider Purchase: Director Thomas Kosasa purchased 1,879,871 shares of OneMedNet for $1.05M at $0.56 each. The stock surged 45.1% on Friday, with Kosasa's investment up approximately 301.2% at its peak, reaching $2.24.

[object Object]
Preview
3.5
11-24Newsfilter
OneMedNet Unveils Redesigned Data Platform, Enhancing Research Efficiency
  • Platform Redesign: OneMedNet showcased its completely redesigned data exploration and cohort-building platform at ISPOR Europe, receiving strong validation from customers and prospects. Built on Palantir Foundry and AIP, the platform reduces research time from days to minutes, significantly enhancing team efficiency.
  • Network Expansion: The iRWD™ network now spans over 2,130 provider sites, covering 47 million unique patients and more than 186 million clinical exams and images. This extensive data infrastructure supports pharmaceutical and healthcare technology firms, driving industry innovation.
  • AI-Driven Search Capabilities: The new platform features AI-driven natural language search for complex discovery tasks, providing real-time availability and longitudinal insights. This advancement allows clients to assess cohort feasibility faster, addressing market demands for rapid response.
  • Recurring Revenue Growth: The platform's tight integration with subscription workflows supports OneMedNet's recurring revenue growth strategy. CEO Aaron Green emphasized that this transformation meets market needs, enabling clients to determine cohort feasibility in minutes, thereby enhancing the company's competitive edge.
[object Object]
Preview
5.0
11-10Newsfilter
OneMedNet Fulfills Revenue Model Commitment with Palantir-Enhanced RWD Subscriptions: Real-Time Feeds & AI Search Features
  • OneMedNet's iRWD™ Platform Launch: OneMedNet Corporation announced the demonstration of its next-generation iRWD™ platform at ISPOR Europe, which utilizes Palantir Technologies' Foundry ecosystem to provide secure, AI-driven analysis of regulatory-grade real-world data (RWD) for life sciences and medical organizations.

  • Innovative Subscription Model: The company introduced a recurring revenue model featuring Live Data Feeds and AI-Driven Conversational Search, transforming static data access into dynamic, on-demand intelligence for real-time insights and decision-making.

  • Market Opportunity and Challenges: The healthcare sector is poised for significant growth, with an estimated US$868 billion opportunity by 2030, but faces challenges in securing high-quality, timely, de-identified clinical multimodal data.

  • Broader Applications Beyond Healthcare: OneMedNet's AI technology not only serves the healthcare industry but also anonymizes data for sectors like finance, retail, and telecom, enhancing data security and enabling innovative applications across various fields.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Onemednet Corp (ONMD) stock price today?

The current price of ONMD is 1.84 USD — it has increased 21.05 % in the last trading day.

arrow icon

What is Onemednet Corp (ONMD)'s business?

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.

arrow icon

What is the price predicton of ONMD Stock?

Wall Street analysts forecast ONMD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ONMD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Onemednet Corp (ONMD)'s revenue for the last quarter?

Onemednet Corp revenue for the last quarter amounts to 177.00K USD, increased 24.65 % YoY.

arrow icon

What is Onemednet Corp (ONMD)'s earnings per share (EPS) for the last quarter?

Onemednet Corp. EPS for the last quarter amounts to -0.01 USD, decreased -85.71 % YoY.

arrow icon

What changes have occurred in the market's expectations for Onemednet Corp (ONMD)'s fundamentals?

The market is revising No Change the revenue expectations for ONMD for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 111.86%.
arrow icon

How many employees does Onemednet Corp (ONMD). have?

Onemednet Corp (ONMD) has 22 emplpoyees as of December 05 2025.

arrow icon

What is Onemednet Corp (ONMD) market cap?

Today ONMD has the market capitalization of 93.59M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free